Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

CD45RB for organ transplant rejection

May 10, 1996

Cel-Sci announces promising results with TB vaccine

May 10, 1996

Axis Genetics scales up CVP production in anticipation of clinical trials

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Positive results obtained in AllerVax Cat trial

May 3, 1996

HemispheRx, Helix will codevelop nucleic acid compounds

May 3, 1996

ALT expected to receive streamlined review at FDA

May 3, 1996

Centeon to codevelop Medarex's MDX-33

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 17, 2025.
Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM
BioWorld
The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.